Suchergebnisse - "Wang, Xinhua"

PubPharm (10)

1

Should DDGP Regimen Be the Standard of Care for Advanced Extranodal NK/T-Cell Lymphoma? The New Staging System Matters-Reply

enthalten in: JAMA oncology | 2023

von Wang, X. | Young, K. | Zhang, M.

CommentOn: JAMA Oncol. 2023 Feb 1;9(2):278-279. - PMID 36480181

2

Radiotherapy vs sequential pegaspargase, gemcitabine, cisplatin and dexamethasone and radiotherapy in newly diagnosed early natural killer/T-cell lymphoma : A randomized, controlled, open-label, multicenter study

enthalten in: International journal of cancer | 2021

von Zhang, L. | Wang, Y. | Li, X. | +15

3

The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus CHOP in patients with newly diagnosed peripheral T-cell lymphoma with analysis of biomarkers

enthalten in: British journal of haematology | 2017

von Li, L. | Duan, W. | Zhang, L. | +12

4

microRNA-520a-3p inhibits proliferation and cancer stem cell phenotype by targeting HOXD8 in non-small cell lung cancer

enthalten in: Oncology reports | 2016

von Liu, Y. | Miao, L. | Ni, R. | +5

5

DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma : A Randomized Controlled, Multicenter, Open-label Study in China

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2016

von Li, X. | Cui, Y. | Sun, Z. | +14

CommentIn: Clin Cancer Res. 2016 Aug 15;22(16):4271. - PMID 27528735

6

Efficacy and safety of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) regimen in newly diagnosed, advanced-stage extranodal natural killer/T-cell lymphoma : interim analysis of a phase 4 study NCT01501149

enthalten in: Oncotarget | 2016

von Zhang, L. | Jia, S. | Ma, Y. | +21

7

Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma : a retrospective study of 17 patients

enthalten in: Annals of hematology | 2014

von Zhou, Z. | Li, X. | Chen, C. | +17

8

Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patients

enthalten in: Annals of hematology | 2014

von Zhou, Z. | Li, X. | Chen, C. | +17

9

Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patients

enthalten in: Annals of hematology | 2014

von Zhou, Z. | Li, X. | Chen, C. | +17

10

Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patients

enthalten in: Annals of hematology | 2014

von Zhou, Z. | Li, X. | Chen, C. | +17

1
[1]